类风湿关节炎疾病活动度、细胞因子与趋化因子与新发糖尿病的风险
该研究基于退伍军人事务部类风湿关节炎登记队列,纳入1866例基线无糖尿病的RA患者,随访9223人年发生130例新发糖尿病。高DAS28-CRP、肥胖BMI、高龄和男性与更高新发糖尿病风险相关,而当前吸烟和甲氨蝶呤使用具有保护作用。IL-1、IL-6及部分巨噬细胞来源的细胞因子/趋化因子独立于DAS28-CRP与新发糖尿病相关。
要点
- 高DAS28-CRP与RA患者新发糖尿病风险升高相关
- IL-1、IL-6及部分巨噬细胞来源因子独立于DAS28-CRP与糖尿病相关
- 甲氨蝶呤使用与较低的新发糖尿病风险相关
核心结论
- 在RA患者中,较高的疾病活动度和升高的细胞因子/趋化因子水平与新发糖尿病风险升高相关。
研究设计与样本
- 来自退伍军人事务部类风湿关节炎登记队列的成人RA患者,基线无糖尿病者1866例,随访9223人年。
- 入组时储存血清中检测30种细胞因子和趋化因子,数值经对数调整并按每标准差标准化。
- 采用多变量Cox比例风险模型评估临床因素与新发糖尿病的关联,并调整年龄、性别、种族、吸烟、BMI和基线用药。
主要发现
- 随访期间共发生130例新发糖尿病。
- 高DAS28-CRP、肥胖BMI、高龄和男性与新发糖尿病风险升高相关,当前吸烟和甲氨蝶呤使用具有保护作用。
- IL-1、IL-6及部分巨噬细胞来源的细胞因子/趋化因子每升高1个标准差与新发糖尿病独立相关,HR范围为1.11-1.26。
- 上述细胞因子/趋化因子与新发糖尿病的关联独立于DAS28-CRP。
临床怎么用
- 在RA管理中,除控制疾病活动度外,应关注高疾病活动度及特定细胞因子/趋化因子升高患者的新发糖尿病风险。
- 甲氨蝶呤使用与较低的新发糖尿病风险相关,但需结合患者具体情况综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Rheumatoid arthritis (RA) is associated with a higher risk of diabetes mellitus (DM). Our aim was to determine associations between inflammatory disease activity (including evaluation of specific cytokines and chemokines) and incident DM. METHODS: Participants were adults with physician-confirmed RA from Veteran's Affairs Rheumatoid Arthritis Registry. Disease activity and clinical assessments occur longitudinally as part of clinical care. Thirty cytokines and chemokines were measured in banked serum obtained at the time of enrolment. Cytokine/chemokine values were log-adjusted and standardised (per SD). Incident DM was defined based on validated algorithms using diagnostic codes and medications. Multivariable Cox proportional hazard models evaluated associations between clinical factors and incident DM. Independent associations between cytokines/chemokines and incident DM were assessed adjusting for age, sex, race, smoking, body mass index (BMI) and medication use at baseline. RESULTS: Among 1866 patients with RA without prevalent DM at enrolment, there were 130 incident cases over 9223 person-years of follow-up. High Disease Activity Score (DAS28)-C reactive protein (CRP), obese BMI, older age and male sex were associated with greater risk for incident DM while current smoking and methotrexate use were protective. Patients using methotrexate were at lower risk. Several cytokines/chemokines evaluated were independently associated (per 1 SD) with DM incidence including interleukin(IL)-1, IL-6 and select macrophage-derived cytokines/chemokines (HR range 1.11-1.26). These associations were independent of the DAS28-CRP. CONCLUSIONS: Higher disease activity and elevated levels of cytokines/chemokines are associated with a higher risk of incident DM in patients with RA. Future study may help to determine if targeted treatments in at-risk individuals could prevent the development of DM.
引用
- Baker JF, England BR, George M, et al. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis. Ann Rheum Dis. 2021. PMID: 33397733. doi:10.1136/annrheumdis-2020-219140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。